Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nuclear Physics | 6 | 2014 | 75 | 0.660 |
Why?
|
Elementary Particles | 4 | 2014 | 52 | 0.450 |
Why?
|
Myeloproliferative Disorders | 4 | 2015 | 613 | 0.430 |
Why?
|
Chromosome Aberrations | 4 | 2013 | 1768 | 0.410 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 2 | 2023 | 174 | 0.390 |
Why?
|
Decidua | 1 | 2011 | 82 | 0.360 |
Why?
|
Hormone Replacement Therapy | 1 | 2016 | 751 | 0.360 |
Why?
|
Abortion, Habitual | 1 | 2011 | 61 | 0.360 |
Why?
|
Cesarean Section, Repeat | 1 | 2009 | 28 | 0.330 |
Why?
|
Receptors, Progesterone | 1 | 2013 | 1129 | 0.310 |
Why?
|
Calreticulin | 3 | 2014 | 114 | 0.310 |
Why?
|
Thrombocythemia, Essential | 3 | 2014 | 113 | 0.310 |
Why?
|
Arsenic | 1 | 2012 | 362 | 0.310 |
Why?
|
Water Pollutants, Chemical | 1 | 2012 | 359 | 0.300 |
Why?
|
Leukemia, Myeloid, Acute | 5 | 2024 | 3613 | 0.290 |
Why?
|
Models, Theoretical | 6 | 2014 | 3575 | 0.290 |
Why?
|
Receptors, Estrogen | 2 | 2022 | 2208 | 0.280 |
Why?
|
Placenta Diseases | 1 | 2009 | 199 | 0.270 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2011 | 517 | 0.270 |
Why?
|
Neuroblastoma | 4 | 2022 | 1250 | 0.250 |
Why?
|
Primary Myelofibrosis | 4 | 2014 | 209 | 0.240 |
Why?
|
Neoplasms, Second Primary | 1 | 2012 | 1052 | 0.230 |
Why?
|
Hypereosinophilic Syndrome | 2 | 2015 | 97 | 0.220 |
Why?
|
Elementary Particle Interactions | 2 | 2013 | 17 | 0.220 |
Why?
|
Janus Kinase 2 | 4 | 2014 | 560 | 0.220 |
Why?
|
Receptor, erbB-2 | 1 | 2013 | 2557 | 0.210 |
Why?
|
Barth Syndrome | 1 | 2022 | 25 | 0.200 |
Why?
|
Killer Cells, Natural | 1 | 2011 | 2200 | 0.190 |
Why?
|
Epigenesis, Genetic | 2 | 2022 | 3802 | 0.180 |
Why?
|
Acyltransferases | 1 | 2022 | 305 | 0.180 |
Why?
|
Registries | 2 | 2017 | 8224 | 0.170 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 382 | 0.170 |
Why?
|
Neutrophils | 2 | 2023 | 3767 | 0.170 |
Why?
|
Candidiasis | 1 | 2022 | 365 | 0.160 |
Why?
|
Toll-Like Receptors | 1 | 2022 | 589 | 0.150 |
Why?
|
Receptors, Thrombopoietin | 3 | 2013 | 160 | 0.150 |
Why?
|
DNA Replication | 1 | 2024 | 1418 | 0.140 |
Why?
|
Mesons | 2 | 2014 | 31 | 0.140 |
Why?
|
Neutropenia | 1 | 2022 | 885 | 0.140 |
Why?
|
Myositis Ossificans | 1 | 2017 | 77 | 0.140 |
Why?
|
Leukemia | 2 | 2022 | 1522 | 0.130 |
Why?
|
Oncogenes | 1 | 2022 | 1222 | 0.130 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2015 | 1606 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-cbl | 2 | 2013 | 120 | 0.130 |
Why?
|
DNA Modification Methylases | 1 | 2015 | 210 | 0.120 |
Why?
|
Ossification, Heterotopic | 1 | 2017 | 235 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2013 | 2825 | 0.120 |
Why?
|
Neutrons | 1 | 2014 | 77 | 0.110 |
Why?
|
Proteins | 2 | 2023 | 6032 | 0.110 |
Why?
|
DNA Repair Enzymes | 1 | 2015 | 346 | 0.110 |
Why?
|
Ovarian Neoplasms | 1 | 2011 | 4876 | 0.110 |
Why?
|
Genome | 1 | 2022 | 1740 | 0.110 |
Why?
|
Pyrazoles | 2 | 2015 | 2009 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 2 | 2015 | 2803 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2013 | 2898 | 0.100 |
Why?
|
Uniparental Disomy | 1 | 2012 | 45 | 0.100 |
Why?
|
Serbia | 1 | 2012 | 13 | 0.100 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2013 | 410 | 0.100 |
Why?
|
Ultrasonography, Prenatal | 2 | 2010 | 1755 | 0.100 |
Why?
|
Nucleotides | 2 | 2024 | 454 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 2 | 2013 | 4511 | 0.090 |
Why?
|
Water Supply | 1 | 2012 | 204 | 0.090 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2011 | 367 | 0.090 |
Why?
|
Multicystic Dysplastic Kidney | 1 | 2010 | 7 | 0.090 |
Why?
|
Karyotyping | 1 | 2012 | 1171 | 0.090 |
Why?
|
Dioxygenases | 1 | 2012 | 345 | 0.090 |
Why?
|
Loss of Heterozygosity | 1 | 2012 | 662 | 0.090 |
Why?
|
beta-Thalassemia | 1 | 2012 | 236 | 0.090 |
Why?
|
Umbilical Arteries | 1 | 2010 | 79 | 0.080 |
Why?
|
Kell Blood-Group System | 1 | 2009 | 21 | 0.080 |
Why?
|
Aromatase Inhibitors | 1 | 2013 | 513 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 3639 | 0.080 |
Why?
|
Erythroblastosis, Fetal | 1 | 2009 | 62 | 0.080 |
Why?
|
Mutation | 4 | 2014 | 30052 | 0.080 |
Why?
|
Cytomegalovirus | 1 | 2013 | 756 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2015 | 8547 | 0.080 |
Why?
|
Blood Group Incompatibility | 1 | 2009 | 135 | 0.080 |
Why?
|
Diagnostic Imaging | 1 | 2022 | 3530 | 0.080 |
Why?
|
Humans | 32 | 2024 | 761504 | 0.080 |
Why?
|
Cell Cycle | 2 | 2013 | 2932 | 0.080 |
Why?
|
Menopause | 1 | 2016 | 1646 | 0.080 |
Why?
|
Mice | 11 | 2024 | 81525 | 0.080 |
Why?
|
Abruptio Placentae | 1 | 2009 | 118 | 0.070 |
Why?
|
RNA Splicing | 1 | 2012 | 918 | 0.070 |
Why?
|
Hedgehog Proteins | 1 | 2012 | 768 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 12148 | 0.070 |
Why?
|
Placenta Previa | 1 | 2009 | 122 | 0.070 |
Why?
|
Protons | 1 | 2013 | 1116 | 0.070 |
Why?
|
Fagopyrum | 1 | 2006 | 1 | 0.070 |
Why?
|
DNA-Binding Proteins | 3 | 2013 | 9606 | 0.070 |
Why?
|
Signal Transduction | 3 | 2024 | 23445 | 0.070 |
Why?
|
Genes, Tumor Suppressor | 1 | 2011 | 1062 | 0.070 |
Why?
|
Pregnancy | 6 | 2011 | 29874 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3778 | 0.070 |
Why?
|
Chromosome Deletion | 1 | 2011 | 1386 | 0.070 |
Why?
|
Cytomegalovirus Infections | 1 | 2013 | 831 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3204 | 0.070 |
Why?
|
Cell Differentiation | 1 | 2024 | 11528 | 0.070 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2012 | 938 | 0.070 |
Why?
|
Breast Neoplasms | 1 | 2013 | 21012 | 0.070 |
Why?
|
Fertility | 1 | 2011 | 771 | 0.070 |
Why?
|
Fetal Growth Retardation | 1 | 2010 | 580 | 0.060 |
Why?
|
Neoplasm Proteins | 2 | 2022 | 3617 | 0.060 |
Why?
|
Female | 18 | 2021 | 392644 | 0.060 |
Why?
|
Placenta Accreta | 1 | 2009 | 237 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 6484 | 0.060 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2013 | 1520 | 0.060 |
Why?
|
Myelodysplastic Syndromes | 2 | 2013 | 1394 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2012 | 1250 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2020 | 5305 | 0.060 |
Why?
|
Gene Regulatory Networks | 1 | 2013 | 1745 | 0.060 |
Why?
|
Repressor Proteins | 2 | 2012 | 2986 | 0.060 |
Why?
|
Transcription Factors | 4 | 2022 | 12128 | 0.060 |
Why?
|
Exons | 3 | 2014 | 2391 | 0.060 |
Why?
|
Animals | 11 | 2024 | 168459 | 0.050 |
Why?
|
S Phase | 1 | 2024 | 421 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2872 | 0.050 |
Why?
|
Disease Progression | 3 | 2017 | 13506 | 0.050 |
Why?
|
Cardiolipins | 1 | 2022 | 81 | 0.050 |
Why?
|
Apoptosis | 2 | 2022 | 9486 | 0.050 |
Why?
|
Polycythemia Vera | 2 | 2013 | 161 | 0.050 |
Why?
|
Cell Cycle Proteins | 1 | 2013 | 3448 | 0.050 |
Why?
|
Ultraviolet Rays | 1 | 2006 | 1080 | 0.050 |
Why?
|
Partial Pressure | 1 | 2021 | 245 | 0.050 |
Why?
|
Cell Degranulation | 1 | 2022 | 277 | 0.050 |
Why?
|
Gases | 1 | 2021 | 204 | 0.050 |
Why?
|
Oxidoreductases | 1 | 2023 | 413 | 0.050 |
Why?
|
Mice, Congenic | 1 | 2020 | 97 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2015 | 9420 | 0.040 |
Why?
|
Cell Line, Tumor | 2 | 2013 | 16981 | 0.040 |
Why?
|
Histone Acetyltransferases | 1 | 2022 | 336 | 0.040 |
Why?
|
Prognosis | 3 | 2022 | 29625 | 0.040 |
Why?
|
Gene Library | 1 | 2022 | 1059 | 0.040 |
Why?
|
Leukemia, Myeloid | 2 | 2013 | 694 | 0.040 |
Why?
|
Nitriles | 2 | 2015 | 971 | 0.040 |
Why?
|
Candida albicans | 1 | 2022 | 372 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7390 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 4414 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12059 | 0.040 |
Why?
|
Antioxidants | 1 | 2006 | 1668 | 0.040 |
Why?
|
Cell Count | 1 | 2022 | 1835 | 0.040 |
Why?
|
DNA | 1 | 2012 | 7212 | 0.040 |
Why?
|
Transgenes | 1 | 2022 | 1010 | 0.040 |
Why?
|
Remission Induction | 2 | 2015 | 2396 | 0.040 |
Why?
|
Pyrimidines | 3 | 2015 | 3028 | 0.040 |
Why?
|
Nuclear Proteins | 3 | 2022 | 5796 | 0.040 |
Why?
|
Animals, Genetically Modified | 1 | 2022 | 1561 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13639 | 0.030 |
Why?
|
Base Sequence | 2 | 2022 | 12441 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2012 | 10445 | 0.030 |
Why?
|
Mice, Nude | 2 | 2013 | 3615 | 0.030 |
Why?
|
Glucose-6-Phosphate Isomerase | 1 | 2015 | 50 | 0.030 |
Why?
|
Phagocytosis | 1 | 2022 | 1528 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1827 | 0.030 |
Why?
|
Benzeneacetamides | 1 | 2015 | 36 | 0.030 |
Why?
|
Pyrans | 1 | 2015 | 49 | 0.030 |
Why?
|
Cell Lineage | 1 | 2024 | 2555 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2020 | 0.030 |
Why?
|
Adult | 7 | 2017 | 221177 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2013 | 6075 | 0.030 |
Why?
|
Aged | 6 | 2021 | 169289 | 0.030 |
Why?
|
Thrombocytosis | 1 | 2013 | 89 | 0.030 |
Why?
|
Vincristine | 1 | 2015 | 1036 | 0.030 |
Why?
|
Veratrum Alkaloids | 1 | 2012 | 23 | 0.030 |
Why?
|
Sulfones | 1 | 2015 | 448 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2023 | 3712 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 12690 | 0.030 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2015 | 287 | 0.030 |
Why?
|
Electrons | 1 | 2014 | 265 | 0.030 |
Why?
|
Ganciclovir | 1 | 2013 | 252 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2012 | 15936 | 0.030 |
Why?
|
Dacarbazine | 1 | 2015 | 559 | 0.030 |
Why?
|
Thermodynamics | 1 | 2014 | 595 | 0.030 |
Why?
|
Immunoblotting | 1 | 2015 | 1646 | 0.030 |
Why?
|
Pyridines | 2 | 2015 | 2875 | 0.030 |
Why?
|
Camptothecin | 1 | 2015 | 591 | 0.020 |
Why?
|
Janus Kinases | 1 | 2013 | 248 | 0.020 |
Why?
|
Codon | 1 | 2013 | 601 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2016 | 0.020 |
Why?
|
Granulocytes | 1 | 2013 | 551 | 0.020 |
Why?
|
Bone Marrow Diseases | 1 | 2013 | 233 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2013 | 4740 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2015 | 718 | 0.020 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2013 | 305 | 0.020 |
Why?
|
Luciferases | 1 | 2012 | 714 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 26125 | 0.020 |
Why?
|
beta Catenin | 1 | 2015 | 1040 | 0.020 |
Why?
|
Medulloblastoma | 1 | 2015 | 678 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2021 | 2720 | 0.020 |
Why?
|
Triazoles | 1 | 2015 | 903 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2960 | 0.020 |
Why?
|
Fetal Monitoring | 1 | 2010 | 69 | 0.020 |
Why?
|
Oxygen | 1 | 2021 | 4227 | 0.020 |
Why?
|
Pyrazines | 1 | 2015 | 1201 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2022 | 3065 | 0.020 |
Why?
|
Thrombosis | 2 | 2013 | 2942 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3877 | 0.020 |
Why?
|
Cisplatin | 1 | 2015 | 1651 | 0.020 |
Why?
|
Male | 7 | 2021 | 360804 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2022 | 9539 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2013 | 682 | 0.020 |
Why?
|
Doxorubicin | 1 | 2015 | 2224 | 0.020 |
Why?
|
Random Allocation | 1 | 2013 | 2395 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 2012 | 718 | 0.020 |
Why?
|
Middle Aged | 4 | 2021 | 220895 | 0.020 |
Why?
|
Genotype | 2 | 2014 | 12990 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2013 | 1125 | 0.020 |
Why?
|
Gene Amplification | 1 | 2012 | 1089 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2023 | 14414 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 2010 | 462 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2013 | 1393 | 0.020 |
Why?
|
DNA, Plant | 1 | 2006 | 52 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2013 | 26198 | 0.020 |
Why?
|
Anxiety | 1 | 2021 | 4573 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 22170 | 0.020 |
Why?
|
Catalase | 1 | 2006 | 218 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2010 | 1496 | 0.020 |
Why?
|
Plant Leaves | 1 | 2006 | 150 | 0.020 |
Why?
|
Pedigree | 1 | 2014 | 4542 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10194 | 0.020 |
Why?
|
Lipid Peroxidation | 1 | 2006 | 271 | 0.020 |
Why?
|
Glycoproteins | 1 | 2013 | 2203 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4111 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4575 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2015 | 5869 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5035 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2013 | 3602 | 0.020 |
Why?
|
Superoxide Dismutase | 1 | 2006 | 594 | 0.010 |
Why?
|
Young Adult | 3 | 2017 | 59243 | 0.010 |
Why?
|
Peroxidase | 1 | 2006 | 609 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2011 | 4615 | 0.010 |
Why?
|
Infant | 2 | 2017 | 36192 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3429 | 0.010 |
Why?
|
Antigens, CD | 1 | 2013 | 4003 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2022 | 18252 | 0.010 |
Why?
|
Child, Preschool | 2 | 2017 | 42230 | 0.010 |
Why?
|
Alleles | 1 | 2013 | 6863 | 0.010 |
Why?
|
Adolescent | 3 | 2017 | 88319 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11076 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22169 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2013 | 2226 | 0.010 |
Why?
|
Peptides | 1 | 2013 | 4358 | 0.010 |
Why?
|
Acute Disease | 1 | 2011 | 7237 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2013 | 3060 | 0.010 |
Why?
|
Glioma | 1 | 2015 | 3455 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 13367 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 17635 | 0.010 |
Why?
|
Cell Line | 1 | 2013 | 15601 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 12463 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2011 | 4936 | 0.010 |
Why?
|
Chronic Disease | 1 | 2013 | 9318 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12795 | 0.010 |
Why?
|
Child | 2 | 2017 | 80153 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54425 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15732 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16591 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6935 | 0.010 |
Why?
|
Kidney | 1 | 2010 | 7048 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2015 | 9031 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 17904 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2015 | 64680 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2013 | 58976 | 0.000 |
Why?
|